Sophia Genetics

Five UK healthcare institutions will use Sophia's Data Driven Medicine Platform, which employs machine learning and algorithms to analyze patients' genomic samples.

The hospitals will use Sophia's Data Driven Medicine Platform to run and validate an NGS-based gene panel that detects mutations for breast and ovarian cancers.

Sophia has developed an algorithm for detecting CNVs from NGS data, and the CE-IVD mark is the second for the company this year.

Sophia Genetics has received ISO 27001 certification for its internally developed information security management system.

NEW YORK (GenomeWeb) – Sophia Genetics, a clinical genomic data analysis services provider, this week launched a new CE-IVD-marked software pipeline that lets clinical researchers identify and characterize genetic variants associated with cystic fibrosis using data from a single next-generation s


Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.